At Price Forbes, we partner with global brokers handling some of the world’s most advanced life sciences businesses to help them navigate this complexity with confidence. Backed by ex-industry experts and strong insurer relationships, we deliver tailored, globally compliant insurance and risk management solutions, from R&D to launch and beyond.
We work with a wide range of organisations across the life sciences value chain:
Whether you’re a pre-revenue biotech or a global pharma business, we know your risk profile, and how to protect it.
We build end-to-end insurance programmes that are responsive to your lifecycle, jurisdiction and exposure:
Many of our clients also benefit from integrated risk solutions across:
Our teams work cross-divisionally to ensure comprehensive protection from product development to distribution.
We understand the pressure points. Our team includes ex-industry professionals who’ve walked in your shoes, launching clinical trials, managing recalls, defending patent risks, and preparing products for global distribution.
We also bring:
We don’t just manage policies, we help shape better outcomes.
It depends on your stage of growth and exposure profile. Early-stage firms typically prioritise clinical trials liability, directors’ and officers’ cover, and IP protection. As you scale, product liability, recall, and business interruption become critical. We work with you to build a phased insurance strategy that evolves with your risk, from R&D to commercialisation.
Absolutely, and they’re often hidden in the detail. Many off-the-shelf policies exclude clinical trials, product recall, or emerging biotech risks. We audit your programme for silent exposures and build specialist solutions to close the gaps, using bespoke wording where necessary.
We provide global trial programmes underpinned by country-compliant policies. Whether you're running a single trial or a multi-site, multi-year portfolio, we issue local documents quickly through in-house binding authority, keeping you compliant and launch-ready.
Yes. We offer standalone recall policies and non-damage business interruption cover to protect against regulatory interventions, manufacturing issues or contamination events. It’s about defending both your revenue and your reputation.
D&O cover protects your leadership team from personal liability linked to company decisions. IP liability guards against patent disputes and licensing issues. Both are essential in a high-growth, high-scrutiny environment, especially if you're raising capital or preparing for M&A.
Yes - we offer cover for adverse outcomes from surgical devices, communicable disease exposure, and trial-linked medical events. Our specialist policies address the nuanced risks of delivering healthcare innovation to a global market.
We look at asset values, dependency on critical inputs (like labs or logistics), and the potential impact of downtime. Our team works with actuaries and insurers to model these risks and negotiate cover that reflects the true cost of disruption, not just the physical damage.
A layered, integrated programme often brings better protection and commercial efficiency. We structure cross-class solutions that reduce duplication, close common exclusions, and simplify renewal and oversight, all while maintaining specialist focus in each area.
Yes. We regularly advise on insurance due diligence and design bespoke risk transfer solutions to support transactions. Whether it’s Warranty & Indemnity cover, valuation protection, or post-close integration, we ensure your deal is backed by the right insurance structure.
Our insurance experts are always on hand to talk about ways we can join forces to take on the future.
